AUD 0.23
(6.98%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 11.12 Million AUD | 81.47% |
2023 | 6.13 Million AUD | -39.17% |
2022 | 10.07 Million AUD | -7.99% |
2021 | 10.95 Million AUD | 1.93% |
2020 | 10.74 Million AUD | 25.02% |
2019 | 8.59 Million AUD | 2.84% |
2018 | 8.35 Million AUD | 1.99% |
2017 | 8.19 Million AUD | 30.97% |
2016 | 6.25 Million AUD | -34.29% |
2015 | 9.52 Million AUD | 15.99% |
2014 | 8.2 Million AUD | 806.72% |
2013 | 905.42 Thousand AUD | -62.41% |
2012 | 2.4 Million AUD | 66.02% |
2011 | 1.45 Million AUD | -78.75% |
2010 | 6.82 Million AUD | -9.81% |
2009 | 7.57 Million AUD | -5.28% |
2008 | 7.99 Million AUD | -21.39% |
2007 | 10.16 Million AUD | 10.89% |
2006 | 9.16 Million AUD | 73.84% |
2005 | 5.27 Million AUD | 482.91% |
2004 | 904.88 Thousand AUD | -63.98% |
2003 | 2.51 Million AUD | -48.99% |
2002 | 4.92 Million AUD | -1.29% |
2001 | 4.98 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q4 | 11.12 Million AUD | 0.0% |
2024 Q2 | 8.68 Million AUD | 0.0% |
2024 FY | 11.12 Million AUD | 81.47% |
2023 Q4 | 6.13 Million AUD | 0.0% |
2023 FY | 6.13 Million AUD | -39.17% |
2023 Q2 | 10.03 Million AUD | 0.0% |
2022 Q2 | 10.66 Million AUD | 0.0% |
2022 Q4 | 10.07 Million AUD | 0.0% |
2022 FY | 10.07 Million AUD | -7.99% |
2021 FY | 10.95 Million AUD | 1.93% |
2021 Q4 | 10.95 Million AUD | 0.0% |
2021 Q2 | 11.57 Million AUD | 0.0% |
2020 Q4 | 10.74 Million AUD | 0.0% |
2020 Q2 | 11.63 Million AUD | 0.0% |
2020 FY | 10.74 Million AUD | 25.02% |
2019 Q4 | 8.59 Million AUD | 0.0% |
2019 Q2 | 8.17 Million AUD | 0.0% |
2019 FY | 8.59 Million AUD | 2.84% |
2018 FY | 8.35 Million AUD | 1.99% |
2018 Q4 | 8.35 Million AUD | 0.0% |
2018 Q2 | 9.02 Million AUD | 0.0% |
2017 Q2 | 8.57 Million AUD | 0.0% |
2017 FY | 8.19 Million AUD | 30.97% |
2017 Q4 | 8.19 Million AUD | 0.0% |
2016 Q4 | 6.25 Million AUD | 0.0% |
2016 Q2 | 9.32 Million AUD | 0.0% |
2016 FY | 6.25 Million AUD | -34.29% |
2015 Q2 | 7.11 Million AUD | 0.0% |
2015 Q4 | 9.52 Million AUD | 0.0% |
2015 FY | 9.52 Million AUD | 15.99% |
2014 Q1 | 8.91 Million AUD | 884.81% |
2014 Q2 | 8.91 Million AUD | 0.0% |
2014 Q4 | 8.2 Million AUD | 0.0% |
2014 FY | 8.2 Million AUD | 806.72% |
2013 Q1 | 1.05 Million AUD | -56.01% |
2013 FY | 905.42 Thousand AUD | -62.41% |
2013 Q4 | 905.42 Thousand AUD | 0.0% |
2013 Q3 | 905.42 Thousand AUD | -14.54% |
2013 Q2 | 1.05 Million AUD | 0.0% |
2012 FY | 2.4 Million AUD | 66.02% |
2012 Q4 | 2.4 Million AUD | 0.0% |
2011 Q4 | 1.45 Million AUD | 0.0% |
2011 FY | 1.45 Million AUD | -78.75% |
2010 Q4 | 6.82 Million AUD | 0.0% |
2010 FY | 6.82 Million AUD | -9.81% |
2009 Q4 | 7.57 Million AUD | 0.0% |
2009 FY | 7.57 Million AUD | -5.28% |
2008 FY | 7.99 Million AUD | -21.39% |
2008 Q4 | 7.99 Million AUD | 0.0% |
2007 Q4 | 10.16 Million AUD | 0.0% |
2007 FY | 10.16 Million AUD | 10.89% |
2006 Q4 | 9.16 Million AUD | 0.0% |
2006 FY | 9.16 Million AUD | 73.84% |
2005 Q4 | 5.27 Million AUD | 0.0% |
2005 FY | 5.27 Million AUD | 482.91% |
2004 FY | 904.88 Thousand AUD | -63.98% |
2004 Q4 | 904.88 Thousand AUD | 0.0% |
2003 Q4 | 2.51 Million AUD | 0.0% |
2003 FY | 2.51 Million AUD | -48.99% |
2002 Q4 | 4.92 Million AUD | 0.0% |
2002 FY | 4.92 Million AUD | -1.29% |
2001 FY | 4.98 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Memphasys Limited | 12.43 Million AUD | 10.501% |
Race Oncology Limited | 20.22 Million AUD | 45.004% |
AdAlta Limited | 5.57 Million AUD | -99.62% |
Anatara Lifesciences Ltd | 1.67 Million AUD | -565.592% |
Bio-Gene Technology Limited | 3.15 Million AUD | -252.098% |
BTC Health Limited | 5.14 Million AUD | -116.067% |
CSL Limited | 56.93 Billion AUD | 99.98% |
Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 92.805% |
Cynata Therapeutics Limited | 8.38 Million AUD | -32.624% |
Imugene Limited | 151.39 Million AUD | 92.652% |
NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -104.656% |
Proteomics International Laboratories Limited | 10.87 Million AUD | -2.296% |
Acrux Limited | 8.96 Million AUD | -24.12% |
Botanix Pharmaceuticals Limited | 112.46 Million AUD | 90.108% |
Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 95.187% |
Island Pharmaceuticals Limited | 2.56 Million AUD | -333.807% |
Nyrada Inc. | 5.9 Million AUD | -88.325% |
Orthocell Limited | 26.61 Million AUD | 58.201% |
Radiopharm Theranostics Limited | 72.03 Million AUD | 84.557% |
Starpharma Holdings Limited | 36.81 Million AUD | 69.781% |
Zelira Therapeutics Limited | 5.18 Million AUD | -114.624% |
Arovella Therapeutics Limited | 13.28 Million AUD | 16.258% |
Alterity Therapeutics Limited | 19.22 Million AUD | 42.13% |
Amplia Therapeutics Limited | 14.84 Million AUD | 25.06% |
Biome Australia Limited | 8.27 Million AUD | -34.41% |
Biotron Limited | 493.47 Thousand AUD | -2154.385% |
Chimeric Therapeutics Limited | 15.27 Million AUD | 27.161% |
EZZ Life Science Holdings Limited | 25.55 Million AUD | 56.462% |
Immutep Limited | 147.44 Million AUD | 92.455% |
Invex Therapeutics Ltd | 6.12 Million AUD | -81.777% |
Noxopharm Limited | 6.78 Million AUD | -63.992% |
Patrys Limited | 4.16 Million AUD | -167.323% |
Prescient Therapeutics Limited | 20.39 Million AUD | 45.447% |
PYC Therapeutics Limited | 91.23 Million AUD | 87.807% |
Telix Pharmaceuticals Limited | 398.3 Million AUD | 97.207% |
Dimerix Limited | 32.07 Million AUD | 65.32% |
Hexima Limited | 2.26 Million AUD | -390.297% |
Neuren Pharmaceuticals Limited | 247.97 Million AUD | 95.514% |
Nanollose Limited | 241.95 Thousand AUD | -4497.976% |
Tissue Repair Ltd | 19.38 Million AUD | 42.625% |
AnteoTech Limited | 9.38 Million AUD | -18.587% |
Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 59.384% |
Recce Pharmaceuticals Ltd | 6.36 Million AUD | -74.655% |
Avecho Biotechnology Limited | 7.31 Million AUD | -51.993% |
Actinogen Medical Limited | 21.31 Million AUD | 47.8% |
Immuron Limited | 15.54 Million AUD | 28.457% |
Argenica Therapeutics Limited | 16.37 Million AUD | 32.073% |